Transforming growth factor-beta (TGF-beta) is central to the wound repair p
rocesses that follow local trauma and inflammation. In order to mimic the e
arly events of wound-healing, we studied the effects of TGF-beta on mitogen
-stimulated peripheral blood cells. TGF-beta added at the initiation of mit
ogenesis did not significantly alter T-cell activation, proliferation. CD45
isoform switching, or activation-induced cell death. By contrast, TGF-beta
added 72 hr post activation (or later) enhanced the cumulative increase in
apoptotic T cells. TGF-beta had no effect on mitogen-induced up-regulation
of Fas (CD95) or Fas ligand and did not enhance killing of the Fas-sensiti
ve Jurkat cell line by activated T cells. Furthermore, TGF-beta had no dire
ct effect on levels of mRNA for members of the bcl family (bcl-X, bfl-1, bi
k, bak, bax, bcl-2 and mol-1). These findings suggest that TGF-beta does no
t directly induce apoptosis via the Fas system or by direct effects on bcl
proteins. However, interleukin-2, which can 'rescue' lymphocytes from spont
aneous apoptosis due to cytokine deprivation. abolished the pro-apoptotic e
ffects of TGF-beta on post-activated T cells. thus demonstrating that TGF-b
eta increases the cytokine-dependence of T cells for survival. We propose a
novel role for TGF-beta in the suppression of inflammation by promoting th
e elimination of post-activated T cells once the initiating stimulus has be
en resolved.